As of April 29, 2025, Elevation Oncology (ELEV) has a market cap of $20.515 million USD. According to our data, Elevation Oncology is ranked No.8557 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $20.52 M |
-38.36%
|
Dec 31, 2024 | $33.28 M |
4.84%
|
Dec 29, 2023 | $31.75 M |
-43.47%
|
Dec 30, 2022 | $56.16 M |
-84.22%
|
Dec 31, 2021 | $0.36 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Blueprint Medicines
BPMC
|
$5.71 B |
-0.000 M
|
![]() USA
|
![]() Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
![]() USA
|
![]() Kura Oncology
KURA
|
$0.53 B |
0.000 M
|
![]() USA
|
![]() Relay Therapeutics
RLAY
|
$0.53 B |
0.000 M
|
![]() USA
|
![]() Revolution Medicines
RVMD
|
$7.56 B |
-0.000 M
|
![]() USA
|
![]() Zymeworks
ZYME
|
$0.88 B |
-0.000 M
|
![]() Canada
|
![]() Cogent Biosciences
COGT
|
$0.57 B |
0.000 M
|
![]() USA
|
![]() Foghorn Therapeutics
FHTX
|
$0.24 B |
0.000 M
|
![]() USA
|
![]() G1 Therapeutics
GTHX
|
$0.38 B |
0.000 M
|
![]() USA
|
![]() Arcus Biosciences
RCUS
|
$0.86 B |
-0.000 M
|
![]() USA
|
![]() Iovance Biotherapeutics
IOVA
|
$1.17 B |
0.000 M
|
![]() USA
|
Market Cap | = | ELEV Stock Price | * | ELEV Shares Outstanding |
= | $0.35 | * | 59.22 M | |
= | $20.52 M |